Accolade's stock surges following proposed $460M acquisition of 2nd.MD

Accolade Inc. has agreed to acquire telemedicine company 2nd.MD in a deal valued at up to $460 million, six months after an initial public offering. The proposed deal sent Accolade's stock up 10% in trading Friday, closing at $52.35 per share. Founded in 2007, Accolade is a technology and health care concierge company that helps people navigate the complexities of medical delivery and workplace benefits. The company has dual headquarters in Seattle, where it had 150 employees as of last September,…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news